Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMIT-DM: Early Insulin Therapy for Type 2 Diabetes Remission
NCT03670641Phase 4Completed
- Start
- Mar 2019
- Primary completion
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine, insulin lispro in type 2 diabetes mellitus (T2DM). Started Mar 2019; status: completed.
02
Drugs
insulin glargineinsulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03670641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03670641.